EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: Identification and evaluation of the resident candidate tumor suppressor genes



The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: Identification and evaluation of the resident candidate tumor suppressor genes



Cancer Research 60(21): 6116-6133, November 1



We used overlapping and nested homozygous deletions, contig building, genomic sequencing, and physical and transcript mapping to further define a apprx630-kb lung cancer homozygous deletion region harboring one or more tumor suppressor genes (TSGs) on chromosome 3p21.3. This location was identified through somatic genetic mapping in tumors, cancer cell lines, and premalignant lesions of the lung and breast, including the discovery of several homozygous deletions. The combination of molecular manual methods and computational predictions permitted us to detect, isolate, characterize, and annotate a set of 25 genes that likely constitute the complete set of protein-coding genes residing in this apprx630-kb sequence. A subset of 19 of these genes was found within the deleted overlap region of apprx370-kb. This region was further subdivided by a nesting 200-kb breast cancer homozygous deletion into two gene sets: 8 genes lying in the proximal apprx120-kb segment and 11 genes lying in the distal apprx250-kb segment. These 19 genes were analyzed extensively by computational methods and were tested by manual methods for loss of expression and mutations in lung cancers to identify candidate TSGs from within this group. Four genes showed loss-of-expression or reduced mRNA levels in non-small cell lung cancer (CACNA2D2/alpha2delta-2, SEMA3B (formerly SEMA(V), BLU, and HYAL1) or small cell lung cancer (SEMA3B, BLU, and HYAL1) cell lines. We found six of the genes to have two or more amino acid sequence-altering mutations including BLU, NPRL2/Gene21, FUS1, HYAL1, FUS2, and SEMA3B. However, none of the 19 genes tested for mutation showed a frequent (>10%) mutation rate in lung cancer samples. This led us to exclude several of the genes in the region as classical tumor suppressors for sporadic lung cancer. On the other hand, the putative lung cancer TSG in this location may either be inactivated by tumor-acquired promoter hypermethylation or belong to the novel class of haploinsufficient genes that predispose to cancer in a hemizygous (+/-) state but do not show a second mutation in the remaining wild-type allele in the tumor. We discuss the data in the context of novel and classic cancer gene models as applied to lung carcinogenesis. Further functional testing of the critical genes by gene transfer and gene disruption strategies should permit the identification of the putative lung cancer TSG(s), LUCA. Analysis of the apprx630-kb sequence also provides an opportunity to probe and understand the genomic structure, evolution, and functional organization of this relatively gene-rich region.

(PDF emailed within 1 workday: $29.90)

Accession: 011464224

Download citation: RISBibTeXText



Related references

The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Research 60(21): 6116-6133, 2000

Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Research 62(9): 2715-2720, 2002

The human homolog of the rodent immediate early response genes, PC4 and TIS7, resides in the lung cancer tumor suppressor gene region on chromosome 3p21. Human Genetics 99(3): 334-341, 1997

Identification of a novel region of homozygous deletion of chromosome 9p in squamous cell carcinoma of the lung: The location of a putative tumor suppressor gene. Cancer Research 57(1): 1-6, 1997

Construction of a 450kB cosmid contig from human chromosome region 3p213 and isolation of candidate tumor suppressor genes for lung cancer. Journal of Cellular Biochemistry Supplement 0(19A): 47, 1995

A candidate tumor suppressor gene, H37, from the human lung cancer tumor suppressor locus 3p21.3. Cancer Research 62(11): 3207-3213, 2002

Two candidate tumor suppressor genes, MEOX2 and SOSTDC1, identified in a 7p21 homozygous deletion region in a Wilms tumor. Genes, Chromosomes & Cancer 48(12): 1037-1050, 2009

Isolation of candidate tumor suppressor genes for human neoplasias mapped to a common region of deletion on chromosome 7q311. American Journal of Human Genetics 61(4 SUPPL ): A62, 1997

Identification and evaluation of candidate tumor suppressor genes at chromosome 22q1331 implicated in the development of sporadic human breast and colorectal cancer. Proceedings of the American Association for Cancer Research Annual Meeting 44: 592, July, 2003

Receptor protein-tyrosine phosphatase c is a candidate tumor suppressor gene at human chromosome region 3p21. Proceedings of the National Academy of Sciences of the United States of America 88: 36-40, 1991

Receptor protein-tyrosine phosphatase gamma is a candidate tumor suppressor gene at human chromosome region 3p21. Proceedings of the National Academy of Sciences of the United States of America 88(11): 5036-5040, 1991

Evaluation of H37, a candidate 3p21.3 tumor suppressor gene, as a therapeutic and diagnostic marker in lung cancer. Chest 125(5 Suppl): 102s-103s, 2004

A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity. Oncogene 8(7): 1721-1729, 1993